Asthika Goonewardene of SunTrust Robinson Humphrey, Downgraded "Allogene Therapeutics, Inc." (ALLO) to Hold and Increased Target from $29 to $32 on, May 14th, 2020.
Asthika has made no other calls on ALLO in the last 4 months.
There is 1 other peer that has a rating on ALLO. Out of the 1 peers that are also analyzing ALLO, all agrees with Asthika's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Shanshan Xu of "Berenberg" Initiated at Hold and Held Target at $27 on, Monday, February 24th, 2020
